Taking GLP-1 medications like Ozempic is linked to a smaller risk of developing epilepsy than taking DPP-4 inhibitors. | Drug ...
A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with ...
A treatment for alopecia areata could move forward despite a setback in a midstage clinical trial.
Pediatric neurosurgeon P. David Adelson, M.D., discusses partnership with Sephos AI on Autonomous Registry and Analytics ...
A mum is looking into taking legal action against Wigan Infirmary over the care given to her young son. Leah Anders, from ...
Financing accelerates development of lead candidate AV078, a CNS-penetrant selective mTORC1 inhibitor, and will fund completion of its Phase 2 clinical trial- Round co-led by Luma Group and CTI Life ...
TipRanks on MSN
Lipocine advances phase 3 trial for PPD treatment
Lipocine ( ($LPCN) ) has shared an announcement. On December 16, 2025, Lipocine announced that its Phase 3 clinical trial for LPCN 1154, an oral ...
Epilepsy is when the brain has an electrical misfire that causes multiple seizures. And depending on where the misfire takes place, the seizure will have different effects, such as freezing you or ...
Encoded Therapeutics Inc. ("Encoded"), a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced the appointment of Dr. Joseph Sullivan M.D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results